These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5423155)

  • 1. Serum calcium in dialyzed uremic patients.
    Hattner RS; Jacobs J; Bernstein DS
    N Engl J Med; 1970 Jul; 283(3):155. PubMed ID: 5423155
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum calcium in dialyzed uremic patients.
    Danesh BJ; Walker CH; Mathers NP
    N Engl J Med; 1970 Jul; 283(3):155-6. PubMed ID: 5423156
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace metal protein binding in normal and dialyzed uremic serum.
    Gidden H; Holland FF; Klein E
    Trans Am Soc Artif Intern Organs; 1980; 26():133-8. PubMed ID: 7245470
    [No Abstract]   [Full Text] [Related]  

  • 5. Zinc, copper, magnesium and calcium in dialyzed and nondialyzed uremic patients.
    Mansouri K; Halsted JA; Gombos EA
    Arch Intern Med; 1970 Jan; 125(1):88-93. PubMed ID: 5410656
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of calcemic status in dialyzed uraemic patients.
    Cannella G; Cristinelli L; Cancarini GC; Maccagnola V; Sandrini S; Maiorca R
    Scand J Clin Lab Invest Suppl; 1983; 165():105-6. PubMed ID: 6578563
    [No Abstract]   [Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionised calcium during haemodialysis.
    Conceicao S; Hoenich NA; Ward MK; White T; Aljama P; Dewar J; Kerr DN
    Proc Eur Dial Transplant Assoc; 1977; 14():229-35. PubMed ID: 23526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Values of active metabolites of vitamin D in the serum of uremic patients on long-term hemodialysis].
    Stefanović V; Kostić S; Dordević V; Grubor-Lajsić G; Mitić-Zlatković M
    Acta Med Iugosl; 1988; 42(2):81-8. PubMed ID: 3389195
    [No Abstract]   [Full Text] [Related]  

  • 10. Endogenous accumulation products and serum protein binding in uremia.
    McNamara PJ; Lalka D; Gibaldi M
    J Lab Clin Med; 1981 Nov; 98(5):730-40. PubMed ID: 7299243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis].
    Szücs J; Steczek K
    Orv Hetil; 1978 May; 119(20):1220-4. PubMed ID: 206866
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Affinity of hemoglobin for oxygen in uremic patients treated with periodic hemodialysis. Comparison of the pre- and post-dialytic phases].
    Bernasconi C; Stabilini R; Graziani G; Agostoni A
    Minerva Med; 1973 Nov; 64(84):4458-62. PubMed ID: 4771470
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum protein values in uremic patients, dialysis-patients and patients with transplanted kidneys].
    Marone C; Flury W; Frey F; Keller H
    Schweiz Med Wochenschr; 1977 Jul; 107(30):1066-72. PubMed ID: 331471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tin-protein binding kinetics in normal and uremic plasma and its effect on dialysis fluxes.
    Maher JF; Montero G; Chieffo S
    Trans Am Soc Artif Intern Organs; 1976; 22():149-54. PubMed ID: 951835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein in the diets of dialyzed and non-dialyzed uremic patients. Study with nitrogen-labeled urea.
    Smith EB; Hill PA
    J Am Diet Assoc; 1972 May; 60(5):389-93. PubMed ID: 5018368
    [No Abstract]   [Full Text] [Related]  

  • 18. Salivary phosphate and calcium concentrations in uremia.
    Blum M; Zurkowsky S; Gilad J; Aviram A
    Clin Nephrol; 1979 Oct; 12(4):191-2. PubMed ID: 509792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA; Evenson MA; Sarver KP; Wagnild JP
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-PTH relationship in dialysis patients: the pitfalls of using a constant dialysate calcium concentration during the dynamic tests.
    De Cristofaro V; Samà F; Pagliari B; Colturi C; Sidoti A; Masa A; Filippini M; Comelli M; Pedrini L
    Clin Nephrol; 1998 Feb; 49(2):113-20. PubMed ID: 9524782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.